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Objective To compare the short-term eff  ects and advantages of transforaminal epidural steroid injection (TFESI) 
performed using the conventional (CL) and posterolateral (PL) approaches.
Method Fifty patients with lumbar radicular pain from lumbar spinal stenosis and herniated lumbar disc were 
enrolled. Subjects were randomly assigned to one of two groups (CL or PL group). All procedures were performed 
using a C-arm (KMC 950, KOMED, Kwangju, Kyunggi, Korea). We compared the frequency of complications 
during the procedure and the effects of the pain block between the two groups at 2, 4, and 12 weeks after the 
procedure.
Results There were no significant differences in the demographic data, initial VNS (Visual numeric scale), or 
ODI (Oswestry disability index) between the CL group (n=26) and the PL group (n=24). Th   ere was no statistically 
signifi  cant diff  erence in the outcome measures (VNS and ODI) between the groups at 2, 4, or 12 weeks. Symptoms 
of nerve root irritation occurred in 1 case of the CL group and in 7 cases of the PL group (p<0.05). Pricking of 
spinal nerve during the procedure and transient weakness after the procedure occurred in 6 cases and 3 cases, 
respectively in the CL group, but did not occur in the PL group.
Conclusion Our fi  ndings suggest that the posterolateral approach represents an alternative TFESI method in cases 
with diffi   cult needle tip positioning in the anterior epidural space, and could lower the risk of target nerve root 
irritation and nerve penetration.
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epidural space: the interlaminar approach, the caudal 
approach, and the transforaminal approach. In theory, 
the transforaminal approach allows the injection needle 
to reach the closest possible position to either the distal 
nerve root or the anterior portion of the epidural space. 
Thus, a low-volume drug can be administered at a high 
concentration to a specific region, and it is likely to 
provide better treatment effects for a longer period of 
time, compared to the other two approaches, which 
were mainly used in the past.
2-4 In the conventional 
transforaminal approach, an injection needle is 
INTRODUCTION
 
  Steroid injections have been used for the treatment 
of lumbar radicular pain since 1952.
1 There are three 
technically different injection methods to access the 
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advanced into the safe triangle under the inferior aspect 
of the pedicle, as described by Bogduk
5 and positioned 
superolaterally to the exiting spinal nerve. In this 
position, a drug can be injected either into the anterior 
epidural space or the site of inflammation between the 
posterior aspect of the herniated disc and the anterior 
aspect of the dural nerve-root sleeve. Since the needle 
passes through the superolateral portion of the neural 
foramen, there is less risk of damaging the dura mater.
6,7 
However, Lee et al.
8 reported that when a conventional 
transforaminal approach is used, the injection needle 
should be placed in the anterior portion of the neural 
foramen across the nerve root. Actually, it is often diffi   cult 
to do so, especially in cases of severe foraminal stenosis. 
Furthermore, as the needle should be directed to the 
anterior epidural space across the neural foramen, it may 
cause damage to the nerve roots. Many arterial blood 
vessels are distributed throughout the space, thus there is 
a risk of severe complications (e.g., paraplegia by spinal 
cord infarction).
9-11 Many other injection approaches 
have been introduced as alternatives to the convention 
al transforaminal approach. As one of such alternative 
option, the posterolateral transforaminal approach 
proposed by Lee et al.
8 carries less risk of drug infusion 
into the anterior radicular artery or of damage to nerve 
roots, because the needle is placed in the posterolateral 
portion of the neural foramen. However, the study by Lee 
et al.
8 had its limitations because it was retrospectively 
conducted and investigated the diagnostic and treatment 
effects over a period of only 2 weeks. Therefore, the 
present study used a prospective randomized method 
in patients diagnosed with lumbar radicular pain. The 
purpose was to compare the conventional transforaminal 
approach and the posterolateral transforaminal approach 
in terms of their treatment eff  ects, injection procedures, 
and possible post-treatment complications over a period 
of 3 months.
MATERIALS AND METHODS
  The subjects were patient volunteers who decided 
to participate in this study being informed about its 
purpose, the procedures involved, and the potential risks 
and complications.
Subjects
  The subjects of this study were selected from those 
patients who visited our hospital’s Department of 
Physical Medicine and Rehabilitation with a complaint of 
lumbar radiculopathy between June 1, 2009 and May 31, 
2010, and received transforaminal injections to treat their 
condition. The patients were considered eligible when 
meeting the following inclusion criteria: 
  (1) Suspected cases of lumbar nerve-root compression, 
as assessed by clinical examination, medical interview 
or electromyography; or (2) Cases of herniated disc or 
spinal stenosis detected by either lumbar CT or MRI of 
the nerve root.
Th   e exclusion criteria were as follows: 
(1) Patients with a systematic infl  ammatory disease 
(2) Patients taking an anticoagulant 
(3) Cases of diabetes that were likely to develop side 
eff  ects from steroid use 
(4) Patients who had previously experienced a side 
eff  ect from the use of lidocaine or contrast medium 
(5) Patients with a known or suspected infectious 
disease 
(6) Patients who found it difficult to visit the hospital 
because of general bad health 
(7) Patients with a skin disorder unsuitable for 
administration of injection at the injection site 
(8) Patients with a mental health problem who were 
unable to complete a questionnaire 
(9) Patients who had received injection treatment in the 
same region in the past 3 months 
(10) Patients who continued to take an anti-infla-
mmatory analgesic other than acetaminophen, or a drug 
that was likely to infl  uence the assessment of treatment 
effects, or received such a treatment (e.g., physical 
therapy) during the clinical trial 
(11) Cases of cauda equine syndrome or a similar disor-
der. 
Randomization
  Th   e investigator randomly assigned the subjects to one 
of two groups after obtaining information on their basic 
characteristics. Th   e subjects received injections by one of 
the following two approaches: 
  (1) Conventional transforaminal approach: 1 cc+2 cc (1.5 
ml of 0.5% lidocaine+20 mg of triamcinolone) of nonionic 
contrast medium (Omnipaque 300; GE Healthcare, Usefulness of Posterolateral Transforaminal Approach in Lumbar Radicular Pain
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Carrigtohill, Co. Cork, Ireland)
  (2) Posterolateral transforaminal approach: 1 cc+2 cc (1.5 
ml of 0.5% lidocaine+20 mg of triamcinolone) of nonionic 
contrast medium (Omnipaque 300; GE Healthcare, 
Carrigtohill, Co. Cork, Ireland) 
  Two weeks after the first injection treatment, the 
patients who showed no eff  ect were excluded. However, 
the patients showing only partial effect, e.g. <50% 
measured on the visual numeric scale (VNS), or even 
<30% measured on the Oswestry disability index, were 
given the second injection two weeks later. Th  e  subjects 
were randomized into two groups by an independent 
investigator who did not have access to the patients’ 
information. 
Injection approaches
  Conventional transforaminal injections: Each patient 
was placed in the prone position with a pillow under the 
abdomen to reduce the lumbar lordosis, and a Scotty 
dog shadow was used to identify the desired lumbar 
region. Th   e C-arm was adjusted to align with the inferior 
endplate of the spine and rotated by 15-30 degrees to an 
oblique position, so that the Scotty dog shadow became 
visible. Th   e target region was disinfected, and a 22-gauge, 
3.5-inch spinal needle (Spinocan
®, BRAUN, Melsungen, 
Germany) was used. The needle was advanced into the 
inferior aspect of the pedicle (safe triangle) towards 
the superior aspect of the neural foramen, in order to 
avoid the nerve roots emerging from the spinal cord. 
When the needle tip reached the inferolateral border, 
the C-arm was rotated to obtain lateral images and the 
needle was slowly advanced towards the anterior aspect 
of the neural foramen. Once the needle was placed in 
the final position, a fine aspiration needle was inserted 
to determine if blood was detected. One cc of nonionic 
contrast medium (Omnipaque 300; GE Healthcare, 
Carrigtohill, Co. Cork, Ireland) was administered 
under real-time fluoroscopic imaging to determine 
if the injection reached the anterior epidural space. 
Every procedure was performed by the same surgeon 
among the authors. After postero-anterior and lateral 
radiographs were taken during contrast administration, 
a 2 cc drug solution (1.5 ml of 0.5% lidocaine+20 mg of 
triamcinolone) was injected.
  Posterolateral transforaminal injections : Th  e  postero-
lateral transforaminal approach used in this study was 
similar to the approach proposed by Lee et al.
8 According 
to them, when using the conventional transforaminal 
approach, because the drug tends to fl  ow into the distal 
portion along spinal nerves, the injection needle on 
an oblique view should be placed in the region where 
a nerve root passes slightly more inferomedially to the 
pedicle. However, the needle should be positioned 
in the posterior portion on a lateral view and in the 
Fig. 1. (A) Anterior-posterior view of the lumbar spine, with superimposed line (1) bisecting the pedicle. Th   is line was drawn 
halfway between the farthest medial (2) and farthest lateral (3) points on the pedicle. (B) Lateral view of the lumbar spine, with 
the quadrant system superimposed. First, a line was drawn tangent to the curve of the spine at the level of interest along the 
posterior vertebral line. (1) A second line (2) was drawn parallel to a this at the posterior margin of the foramen. Next, 2 lines 
perpendicular to lines 1 and 2 were drawn at the superior and inferior margins of the foramen (3 and 4, respectively). Finally, 
line (5) was drawn bisecting 1 and 2, and likewise line (6) bisecting 3 and 4. Th   is divided the foramen into 4 quadrants. Arrow: 
needle position.Ji Woong Park, et al.
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lateral portion under the pedicle on a postero-anterior 
radiograph. Th   is approach allows the doctor to guide the 
injection needle into a target site while seeing oblique 
and lateral views at the same time, using the bi-planar 
C-arm. Therefore, on the oblique view, the needle can 
be safely advanced into the inferomedial aspect of the 
respective pedicle, through which a nerve root passes. 
However, we lacked the required equipment and thus had 
to continue to observe the lateral view while injecting. 
Because this was likely to cause prolonged exposure 
to radiation and damage the nerve root, we placed the 
needle at the 6 o’clock position of the pedicle on an 
oblique view, similar to the conventional transforaminal 
approach. To prevent both damage to the dural sleeve 
and drug infusion into the subarachnoid space, and to 
reduce vascular injuries and discomfort from injection, 
we placed the needle on a site off   the lateral region, with 
the pedicle bisected on postero-anterior radiographs and 
placed in the postero-superior portion on lateral view. 
The neural foramen was divided into four equal parts 
on the lateral radiographs, using the method suggested 
by Crall et al.
12 to distinguish the neural foramen (Fig. 
1). Once the needle tip was in its final position, the 
investigator administered 1 cc of nonionic contrast 
(Omnipaque 300; GE Healthcare, Carrigtohill, Co. Cork, 
Ireland) under real-time fl  uoroscopic imaging to observe 
the spreading range and patterns of the contrast medium. 
We then injected the prepared 2 cc drug solution (1.5 ml 
of 0.5% lidocaine+20 mg of triamcinolone) (Fig. 2). 
Comparison of injection results between the two 
approaches
  The complications that occurred during and after 
injections were recorded for comparison. To compare 
the eff  ects of the injection treatment, we determined the 
pain intensity using the visual numeric rating scale (VNS), 
at baseline and at weeks 2, 4, and 12 of treatment. A pain 
measuring tool within a 100 mm visual line was shown 
to patients. Pain was rated on an 11-point scale, ranging 
from no pain=0, to worst severe pain=10. The patients 
Fig. 2. C-arm guided posterolateral approach. (A) AP fluoroscopic image 
confi  rms needle position just farthest inferior-lateral of pedicle. (B) Lateral view 
shows the needle located in the posterior and superior of the intervertebral 
foramen. (C) Needle was placed adjacent to the L4 nerve root. Contrast injection 
observed with AP view confirms epiradicular location of the needle’s tip with 
contrast tracking along the nerve as well as entering the epidural space locally.Usefulness of Posterolateral Transforaminal Approach in Lumbar Radicular Pain
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were asked to indicate their pain level on the scale. For 
patients who found it difficult to rate their pain, the 
investigator moved a pointer slowly along the scale, from 
the 0 point to the opposite direction. The patients were 
asked to nod their heads when the pointer reached an 
appropriate position. The degrees of physical disability 
were measured using the Oswestry Disability Index 
(ODI), which is a measure designed to assess physical 
disability. In this study, physical disability was presented 
as percentage levels ranging from no disability=0% 
to most severe disability=100%. The subjects were 
asked to complete a questionnaire, and based on the 
questionnaire results, the disability levels of the patients 
were assessed at baseline and at weeks 2, 4, and 12 of 
treatment. 
Statistics 
  Th   e chi-square test and the independent t-test were used 
to compare the two groups of patients in terms of age, 
sex, body mass index (BMI), disease duration, injection 
frequency, and radiologic results. Th   e independent t-test 
was conducted to compare the ODI scores of the VNS 
between the two groups at each treatment time point. 
A repeated measures analysis of variance (ANOVA) was 
used to assess injection eff  ects over time, and Bonferroni’s 
correction was applied for post hoc comparisons. The 
Fisher’s exact test was performed for comparisons of 
possible complications and injection-related discomfort 
in the two groups. Data were statistically analyzed with 
a significance level of p≤0.05, using the SAS Enterprise 
Guide, version 4.1 (4.1.0.471) software. 
RESULTS 
General characteristics of the subjects
  This study included a total of 50 subjects. They were 
grouped to undergo one of the two injection approaches 
as follows: 26 subjects were assigned to the “conventional 
transforaminal approach” group (mean age=52.50±9.94 
years) and 24 were assigned to the “posterolateral 
transforaminal approach” group (mean age=53.50±9.09 
years). There was no statistically significant difference 
between the two groups in the following measurements: 
male-female ratio, body mass index, painful duration, 
injection frequency, lesion site, and radiologic results 
(Table 1).
Patient ﬂ  ow
A total of 66 patients were enrolled as subjects in this 
study. Seven were dropped from the study according to 
our exclusion criteria. Two subjects in the posterolateral 
group were excluded from the study because they showed 
no treatment eff  ect at week 2. In the middle of the study, 
one subject from the posterolateral group and two from 
the conventional group were dropped because they 
transferred to a diff  erent medical department for surgical 
Table 1. Characteristics of the Patients
Conventional approach (n=26) Posterolateral approach (n=24) p-value
Age (year) 52.50±9.94 53.50±9.09 0.712
Male  11 (42.3%)  11 (45.8%)
Female  15 (57.3%)  13 (54.2%) 0.802
BMI (kg/m
2) 23.26±1.46 23.34±1.49 0.856
Duration (Month)   7.77±2.79   7.42±2.92 0.665
No. of injection    1.35±0.485   1.33±0.482 0.926
Spinal stenosis  17 (65.4%)  16 (66.7%)
HLD    9 (34.6%)    8 (33.3%) 0.924
Injection level
L2-3    1 (3.8%)    0 (0%)
L3-4    2 (7.7%)     1 (4.2%)
L4-5    9 (34.6%)    7 (29.2%)
L5-S1  14 (53.8%)  16 (66.7%) 0.651
Values are mean±standard deviation
BMI: Body mass index, HLD: Herniated lumbar discJi Woong Park, et al.
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treatment. One patient in the conventional group was 
also dropped for taking a drug other than acetaminophen 
during the study. In addition, three other patients were 
excluded halfway through the study, as it became diffi   cult 
for them to regularly visit the hospital. 
Treatment eﬀ  ects
  At weeks 2, 4, and 12 of treatment, as well as at baseline, 
there was no statistically significant difference between 
the two investigated groups with regard to the ODI and 
the VNS (Fig. 3, 4). For the treatment effectiveness over 
time after the injection procedure, both groups showed 
a significant decrease in the VNS score compared to 
baseline. The effect was maintained until weeks 4 and 
12 of treatment (Fig. 3). The ODI was also significantly 
improved in both groups, compared to baseline, and 
such improvement continued until weeks 2, 4, and 12 of 
treatment (Fig. 4).
Injection procedures and post-treatment complications 
  During drug injection, we found nerve root irritation in 
seven cases from the conventional group and one case 
in the posterolateral group. During needle insertion, 
we found nerve-root pricking in six cases, all from the 
conventional group. As a result, there were significant 
differences between the two groups in the number of 
such cases. Although three cases of intravascular infusion 
were observed only in the conventional group, there 
was no statistically significant difference between the 
two groups. Muscle weakness caused after treatment 
was found in three cases, all in the conventional group; 
however, for this measurement, there was no statistically 
significant difference between the two groups. Dural 
puncture and other similar complications did not occur 
in either of the studied groups during the treatment 
procedures (Table 2). After the transfer of subjects to 
the recovery room, the progress of all complications was 
observed. No subject showed any complication when 
discharged from the hospital.
DISCUSSION
  One important possible cause of nerve root irritation 
is the mechanical compression exerted by degenerative 
changes in the intervertebral disc, the posterior 
longitudinal ligament or the intervertebral joint. Another 
cause is chemical irritation produced by phospholipase 
A2 or by the substance P secreted from the herniated 






Root irritation (%) 7 (26.9%) 1 (4.2%) 0.050
Spinal nerve pricking (%) 6 (23.1%) 0 (0%) 0.023
Intra-vascular injection (%) 3 (11.5%) 0 (0%) 0.236
Transient weakness (%) 3 (11.5%) 0 (0%) 0.236
Dural puncture 0 (0%) 0 (0%)
CL: Conventional approach, PL: Posteriolateral approach
*Compared by Fisher’s exact test
Fig. 4. Comparative response from ODI preinjection, 2 
weeks, 1 month, 3 months for conventional approach and 
posterolateral approach. *Statistically significant at p<0.05 
within groups. 
Fig. 3. Comparative response from VNS preinjection, 2 
weeks, 1 month, 3 months for conventional approach and 
posterolateral approach. *Statistically significant at p<0.05 
within groups. Usefulness of Posterolateral Transforaminal Approach in Lumbar Radicular Pain
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disc. As a result, they contribute to the pain generation 
by triggering venous congestion and/or neural edema 
around the nerve root.
13-15
  Many different causes of pain have been known or 
reported. When injected in the human body, steroids 
ease pain by inhibiting prostaglandin synthesis, blocking 
the conduction of nociceptive C-fibers, and controlling 
the edema around nerve roots.
16-19 For this reason, steroid 
injections are used in patients with herniated disc or 
lumbar spinal stenosis.
  Th   e conventional transforaminal approach allows a high 
dose of steroid or anesthetic preparation to be eff  ectively 
injected into the anterior epidural space through the safe 
triangle described by Bogduk
5 and around the nerve root 
and the proximal portion of the intervertebral disc. Since 
the neural structures are typically located at the medial 
aspect of neural foramen, neurological complications 
can occur as the injection needle is medially advanced.
20 
Bogduk et al.
21 proposed that if injections were given 
through the safe triangle, they could reduce the 
occurrence of neurological complications such as 
severe loss of disc height or spondylosis, which is the 
deformation of the anatomic structures that constitute 
the safe triangle. Injections given through the safe 
triangle can trigger complications, such as dural tears 
and subarachnoid drug infusion.
22 In the anatomical 
relations, the dorsal root ganglia are reported to be 
located immediately below the pedicle in 90% of the 
cases, in the medial portion of the pedicle in 2%, and 
below the lateral aspect of the pedicle in 8%.
23 Th  erefore, 
even in a normal state where there is no deformation of 
the anatomic structures constituting the intervertebral 
foramen, the injections made through the safe triangle 
can’t ensure safety. In this study, according to the 
injection approach proposed by Crall et al.,
12 the pedicle 
was bisected on a postero-anterior view and the needle 
was placed for drug injection in its lateral segment.
  Complications such as dural tears and subdural drug 
infusion were not found in any of the two groups. This 
may have happened because the sample size was too 
small, similar to findings of a previous study
24 that 
reported an incidence of 0.82% subdural injections 
during the use of the interlaminar injection approach; 
thus, further larger-scale studies are required.
  Lee et al.
8 suggested that when the conventional 
transforaminal approach is performed in cases of severe 
foraminal stenosis, there is a risk of pricking the spinal 
nerve roots during the injection. This happens because 
the injection needle is positioned in the anterior portion 
of the neural foramen across the nerve roots. In contrast, 
the posterolateral transforaminal approach carries less 
risk of pricking because the needle is positioned in 
the superior-posterior aspect on a lateral radiograph. 
Similarly, in our study, the conventional transforaminal 
approach produced needle pricking in six subjects with 
severe foraminal stenosis and severe loss of disc height, 
but there was no such event when the posterolateral 
transforaminal approach was used (p<0.05).
  The incidence of intravascular drug infusion in the 
transforaminal approach is reported to be 9-26%, de-
pending on the location of the injection needle.
25-28 Derby 
et al.
29 reported an incidence of 0.56% for intra-arterial 
drug infusion, which can lead to severe disability. The 
Adamkiewicz artery supplies blood to the inferior 2/3 of 
the spinal cord, branches out from the aorta, and enters 
the spinal canal through one of the T7-L2 intervertebral 
foramina. When entering into the foramen, it passes in 
close proximity to the dorsal root ganglia. In −80% of 
cases, the Adamkiewicz artery is located on the left side 
of T9-L1, the superior or middle portion of the neural 
foramen, and the anterior superolateral aspect of the 
dorsal root ganglion.
30 Therefore, as the conventional 
transforaminal approach has the needle placed on the 
anterior superolateral aspect of the neural foramen, the 
use of this injection approach can cause direct damage 
to the Adamkiewicz artery or can trigger complications, 
such as spinal infarction by intravascular injection 
of particulate steroids. In contrast, the posterolateral 
transforaminal approach has the needle placed on the 
postero-superior aspect of the neural foramen and can 
reduce the risk of such complications. However, when 
a drug is injected into blood vessels that constitute a 
venous plexus in the posterolateral aspect of the epidural 
space, it is difficult to achieve the desired treatment 
effect because of systemic administration. Accordingly, 
the intravascular spread of contrast medium should 
be monitored even when using the posterolateral 
injection approach. In this study, although there was 
no statistically significant difference between the two 
groups, the accidental intravascular infusion of contrast 
was found in three cases in the conventional approach 
group, but no cases were found in the posterolateral Ji Woong Park, et al.
402 www.e-arm.org
approach group. Even though the contrast medium 
was injected not into arterial, but into venous vessels in 
both groups, the above fi  nding suggests that proper care 
should be taken with injection.
  Among minor complications that occur after a foraminal 
injection, the radicular pain may become severe during 
or after the injection procedure. Radicular pain has been 
reported with an average incidence of 4%.
31,32 Such pain 
occurs as a large dose of drug is injected into the spinal 
canal, previously narrowed due to herniated disc, spinal 
canal stenosis, or epidural fibrosis.
33 Pfirrmann et al.
34 
proposed the lateral region of the safe triangle as the ideal 
needle location, producing less pain during treatment. 
Lee et al.
8 reported that when using the posterolateral 
transforaminal approach, patients were less likely to 
complain of discomfort compared with the conventional 
approach. Pain can be minimized when a drug injection 
is given slowly, at a rate of 0.25 cc per second.
35 However, 
nerve root irritation is not always signifi  cant. Usually, if 
the medication has not been injected into the nerve root 
sheath, it means that the needle has been inserted into 
the correct site. Th   ere is a disadvantage, i.e., the patients 
might feel radicular pain during the injection procedure. 
However, they are expected to get the best possible eff  ect 
from the treatment via posterolateral transforaminal 
injections. In this study, eight subjects complained of 
radicular pain during the drug injection: seven cases in 
the conventional group and one case in the posterolateral 
group (p<0.05).
  A fibrotic band divides the posterior aspect of the 
epidural space into the right and left sides, and it extends 
from the dorsal side of the dura to the ligamentum 
flavum. We named this band the “plica mediana 
dorsalis.”
36 There is also connective tissue extending 
from the fibrotic structure into both sides, and the 
posterior aspect of the epidural space is redivided into 
two parts. When an interlaminar approach is used, it 
sometimes prevents a posteriorly injected drug from 
going into the anterior epidural space.
37 Our study found 
no symptom improvement in two subjects who received 
a posterolateral transforaminal injection. Two weeks 
later, when a conventional transforaminal injection was 
performed in the same subjects, both of them showed 
pain relief of >50%. Manchikanti et al.
5 reported in their 
study of 100 patients that the spread of contrast into 
the posterior epidural space was found in 9% of 256 
conventional transforaminal injections. The contrast 
medium injected into the epidural space diffused 
through the region of lowest resistance. Based on these 
findings, they suggested that when there is a herniated 
disc or severe spinal stenosis, medications must not be 
injected into the anterior epidural space, because of 
the strong resistance of the space resulting from such a 
condition. As a result, an injected drug will stay in the 
posterior epidural space due to the strong resistance 
of the anterior epidural space and/or other anatomic 
structures, such as the above mentioned plica mediana 
dorsalis. This is probably the reason why we found no 
treatment effect from the first injection in those two 
subjects presented above.
  In the posterolateral transforaminal approach, as 
medications are injected into the posterolateral epidural 
space, they are not likely to enter the anterior epidural 
space, which is the lesion. Conceivably, this can reduce 
the treatment effects, but the present study found no 
statistically significant difference. When observing the 
progress of patients for two weeks after an injection, 
Lee et al.
8 also reported that there was no difference 
between the two injection approaches with regard to 
the effectiveness of the diagnostic treatment. Crall et 
al.
12 conducted a retrospective study in which they 
divided the intervertebral foramen into four parts and 
assessed the treatment effects immediately after giving 
an injection to each part. They reported no statistically 
signifi  cant diff  erence between the conventional and the 
posterolateral approaches.
  Similarly, we did not find any significant difference 
in the treatment effectiveness, but the study results 
indicate that when the posterolateral transforaminal 
approach was performed with a 2-cc injection dose and 
drug concentration, it was likely to provide sufficient 
medication eff  ects by overcoming the distance from the 
posterolateral epidural space to the anterior epidural 
space of the lesion site. However, when using the 
posterolateral approach, a drug cannot be injected at 
a high concentration into the anterior epidural space, 
compared with the conventional approach. Th  erefore,  the 
progress assessment over 3 months may not be enough 
for comparison of the treatment eff  ects. Future long-term 
studies of 6 or more months are required to examine the 
interactions between treatment effects and either drug 
dosage or injection sites.Usefulness of Posterolateral Transforaminal Approach in Lumbar Radicular Pain
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  This study was limited in that the number of subjects 
(sample size) was too small; and furthermore, it did 
not consider the interactions between treatment effects 
and factors that can aff  ect the pain index (i.e., results of 
physical exam, patient mood, general health measures, 
and smoking status). Future studies need to be conducted 
as long-term attempts to overcome such limitations.
CONCLUSION
  Th   e posterolateral transforaminal approach is an alter-
native option to the conventional transforaminal method, 
when it is difficult to place the needle in the anterior 
epidural space. 
  Comparatively, it can reduce both nerve root irritation 
and patient discomfort, and it carries less risk of pricking 
the spinal nerve roots. 
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